Clorox price target lowered to $140 from $150 at Evercore ISI

Evercore ISI analyst Javier Escalante lowered the firm’s price target on Clorox (CLX) to $140 from $150 and keeps an Underperform rating on the shares after Clorox reported modest sales and earnings misses, which “were not a surprise given the volatile consumer and retail environments.” Clorox’s core controversy remains centered on whether sales can accelerate, sustainably, to a 3-5% rate through the deployment of digital marketing, the analyst tells investors in a post-earnings note.